ESTIMATED
05/08/2024
05/08/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | $2.35 | $2.35 | $2.35 |
Q2 2024 | 5 | $1.94 | $2.02 | $1.98 |
Q3 2024 | 1 | $2.16 | $2.16 | $2.16 |
Q4 2024 | 1 | $2.36 | $2.36 | $2.36 |
Q1 2025 | 2 | $2.65 | $2.65 | $2.65 |
Q2 2025 | 2 | $2.23 | $2.23 | $2.23 |
Q3 2025 | 2 | $2.38 | $2.38 | $2.38 |
Q4 2025 | 2 | $2.57 | $2.57 | $2.57 |
Q1 2026 | 1 | $2.86 | $2.86 | $2.86 |
Q2 2026 | 1 | $2.45 | $2.45 | $2.45 |
Q3 2026 | 1 | $2.59 | $2.59 | $2.59 |
Q4 2026 | 1 | $2.83 | $2.83 | $2.83 |
Q1 2027 | 1 | $3.28 | $3.28 | $3.28 |
STERIS plc last posted its earnings results on Wednesday, May 8th, 2024. The company reported $2.41 earnings per share for the quarter, topping analysts' consensus estimates of $2.35 by $0.06. The company had revenue of 1.42 B for the quarter and had revenue of 5.14 B for the year. STERIS plc has generated $4 earnings per share over the last year ($3.81 diluted earnings per share) and currently has a price-to-earnings ratio of 56.87. STERIS plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 30th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/29/2024 | Q4 2024 | -$0.01 | $1.41 B | $1.42 B | 02/08/2024 | Q3 2024 | $1.42 | $1.35 B | $1.40 B | 11/07/2023 | Q2 2024 | $2.05 | $1.17 | -0.88 | $1.34 B | 08/08/2023 | Q1 2024 | $1.25 | $1.28 B | 05/10/2023 | Q4 2023 | $2.15 | $1.89 | -0.26 | $1.27 B | $1.38 B | 02/08/2023 | Q3 2023 | $2.22 | $1.24 | -0.98 | $1.27 B | $1.22 B | 11/09/2022 | Q2 2023 | $2.00 | -$3.15 | -5.15 | $1.20 B | 08/08/2022 | Q1 2023 | $1.11 | $1.16 B | 05/31/2022 | Q4 2022 | $0.52 | $1.21 B | 02/09/2022 | Q3 2022 | $1.44 | $1.19 B | $1.21 B | 11/08/2021 | Q2 2022 | $0.70 | $1.15 B | $1.20 B | 08/09/2021 | Q1 2022 | $1.50 | -$0.24 | -1.74 | $904.86 M | $968.42 M | 05/28/2021 | Q4 2021 | $1.02 | $873.53 M | 02/09/2021 | Q3 2021 | $1.34 | $793.03 M | $808.92 M | 11/06/2020 | Q2 2021 | $1.24 | $719.54 M | $756.13 M | 08/07/2020 | Q1 2021 | $1.05 | $643.38 M | $668.93 M | 05/29/2020 | Q4 2020 | $1.45 | $822.99 M | 02/10/2020 | Q3 2020 | $1.42 | $1.24 | -0.18 | $748.45 M | $774.26 M | 11/07/2019 | Q2 2020 | $1.12 | $717.79 M | $736.84 M | 08/07/2019 | Q1 2020 | $1.00 | $674.07 M | $696.80 M |
---|
A. STERIS plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 30th, 2024 based off last year's report dates.
A. In the previous quarter, STERIS plc (NYSE:STE) reported $2.41 earnings per share (EPS) to beat the analysts' consensus estimate of $2.35 by $0.06.
A. The conference call for STERIS plc's latest earnings report can be listened to online.
A. The conference call transcript for STERIS plc's latest earnings report can be read online.
A. STERIS plc (NYSE:STE) has a recorded annual revenue of $5.14 B.
A. STERIS plc (NYSE:STE) has a recorded net income of $5.14 B. STERIS plc has generated $3.83 earnings per share over the last four quarters.
A. STERIS plc (NYSE:STE) has a price-to-earnings ratio of 56.87 and price/earnings-to-growth ratio is 3.68.